Stockscreener 앱 받기
4.96
4.64%
0.22
전일 마감가:
$4.74
열려 있는:
$4.8
하루 거래량:
65,715
Relative Volume:
0.27
시가총액:
$58.46M
수익:
$52.29M
순이익/손실:
$-73.52M
주가수익비율:
-7.5152
EPS:
-0.66
순현금흐름:
$-100.45M
1주 성능:
+5.31%
1개월 성능:
+2.06%
6개월 성능:
-16.36%
1년 성능:
-48.97%
1일 변동 폭
$4.78
$4.97
1주일 범위
$4.5362
$4.99
52주 변동 폭
$3.61
$11.09
Precision Biosciences Inc Stock (DTIL) Company Profile
명칭
Precision Biosciences Inc
전화
919-314-5512
주소
302 EAST PETTIGREW STREET, DURHAM, NC
DTIL을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DTIL
Precision Biosciences Inc
|
4.96 | 58.35M | 52.29M | -73.52M | -100.45M | -0.66 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Precision Biosciences Inc Stock (DTIL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-01-10 | 업그레이드 | BMO Capital Markets | Market Perform → Outperform |
| 2024-04-30 | 개시 | Guggenheim | Buy |
| 2022-06-17 | 개시 | BMO Capital Markets | Outperform |
| 2022-06-09 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2020-07-27 | 재개 | BTIG Research | Buy |
| 2020-04-03 | 다운그레이드 | Goldman | Buy → Neutral |
| 2020-03-05 | 개시 | Stifel | Buy |
| 2020-02-25 | 개시 | William Blair | Outperform |
| 2019-08-09 | 개시 | BTIG Research | Buy |
| 2019-07-16 | 개시 | H.C. Wainwright | Buy |
| 2019-04-22 | 개시 | Barclays | Overweight |
| 2019-04-22 | 개시 | Goldman | Buy |
| 2019-04-22 | 개시 | JP Morgan | Overweight |
| 2019-04-22 | 개시 | Jefferies | Buy |
모두보기
Precision Biosciences Inc 주식(DTIL)의 최신 뉴스
How high can Precision BioSciences Inc. stock go2025 Top Decliners & Proven Capital Preservation Methods - Newser
Layoff Tracker: Opthea Slashes 80% of Workforce, 50% of Board - BioSpace
Will Precision BioSciences Inc. continue its uptrendGold Moves & AI Driven Stock Movement Reports - Newser
Precision BioSciences Inc.’s volatility index tracking explainedWeekly Profit Report & Reliable Volume Spike Trade Alerts - Newser
Will Precision BioSciences Inc. stock go up soonWeekly Profit Report & Verified Stock Trade Ideas - Newser
Tools to assess Precision BioSciences Inc.’s risk profileJuly 2025 Market Mood & Real-Time Volume Trigger Notifications - Newser
Visual analytics tools that track Precision BioSciences Inc. performanceWeekly Market Outlook & Free Weekly Watchlist of Top Performers - Newser
Published on: 2025-08-19 13:56:05 - Newser
Will breakout in Precision BioSciences Inc. lead to full recovery2025 Retail Activity & High Return Stock Watch Alerts - Newser
Published on: 2025-08-17 21:42:46 - Newser
How Precision BioSciences Inc. stock performs during market volatilityJuly 2025 Drop Watch & Comprehensive Market Scan Insights - Newser
Can momentum traders help lift Precision BioSciences Inc.Market Risk Report & Free Low Drawdown Momentum Trade Ideas - Newser
Can Precision BioSciences Inc. recover in the next quarterMarket Sentiment Review & Safe Swing Trade Setup Alerts - Newser
Why Precision BioSciences Inc. stock attracts strong analyst attentionRisk Management & Fast Moving Market Watchlists - Newser
Precision Biosciences shares fall 1.89% premarket after Tyra Biosciences reports financial results and corporate progress. - AInvest
Precision BioSciences Reports Significant Quarterly Loss - TipRanks
Precision BioSciences (DTIL) Reports Q2 Loss, Lags Revenue Estimates - MSN
Applying Elliott Wave Theory to Precision BioSciences Inc.Algorithmic Forecast for Swing Trading Picks - Newser
Is Precision BioSciences Inc. stock entering bullish territorySafe Investment Ideas with Growth Upside - Newser
Precision BioSciences: Q2 Earnings Snapshot - Connecticut Post
DTIL Revenue Drops 99% - AOL.com
Precision BioSciences Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Precision BioSciences Reports Second Quarter 2025 Financial Results and Provides Business Update - BioSpace
Precision BioSciences Reports Second Quarter 2025 Financial Resu - GuruFocus
TR | OpenAI4o Maintains Precision BioSciences(DTIL.US) With Hold Rating, Maintains Target Price $5 - 富途牛牛
Precision BioSciences Reports Breakthrough: 69% HBV Reduction and FDA Recognition for DMD Program - Stock Titan
Precision BioSciences Announces Phase 1 Safety and Efficacy for Cohort 1, Lowest Dose Level in ELIMINATE-B, a First-In-Human Trial of PBGENE-HBV for Chronic Hepatitis B - Pipelinereview
Positive Outlook for Precision BioSciences Amid Promising Clinical Trial Data and Strategic Advancements - TipRanks
Precision BioSciences Reports Promising Phase 1 Trial Results - TipRanks
Precision BioSciences Announces Phase 1 Safety and Efficacy for - GuruFocus
Precision BioSciences reports positive data for hepatitis B gene therapy By Investing.com - Investing.com Canada
Using R and stats models for Precision BioSciences Inc. forecastingPredictive AI Engine for Smart Investing - Newser
Precision BioSciences announces Phase 1 safety and efficacy for cohort 1, lowest dose level in Eliminate-B, a first-in-human trial of PBGENE-HBV for Chronic Hepatitis B - MarketScreener
Precision BioSciences Inc expected to post a loss of $1.57 a shareEarnings Preview - TradingView
Precision BioSciences to Report Second Quarter 2025 Results on August 7, 2025 - BioSpace
Published on: 2025-08-04 08:00:09 - beatles.ru
Precision BioSciences: A Strategic Play in the Gene Editing Revolution Amid Q2 Momentum and Regulatory Breakthroughs - AInvest
Precision BioSciences Inc. Stock Analysis and ForecastRemarkable growth - Jammu Links News
Is Precision BioSciences Inc. stock overvalued or undervaluedGet exclusive market insights for better trading - Jammu Links News
What institutional investors are buying Precision BioSciences Inc. stockInvest in stocks with long-term growth potential - Jammu Links News
What is Precision BioSciences Inc. company’s growth strategyRealize consistent double-digit growth - Jammu Links News
Does Precision BioSciences Inc. stock perform well during market downturnsCapitalize on high-growth stocks early - Jammu Links News
When is Precision BioSciences Inc. stock expected to show significant growthMaximize profits with strategic stock selection - Jammu Links News
Using data filters to optimize entry into Precision BioSciences Inc.Free Real-Time Market Sentiment Tracking Tool - Newser
What are the latest earnings results for Precision BioSciences Inc.Achieve rapid portfolio appreciation today - Jammu Links News
What catalysts could drive Precision BioSciences Inc. stock higher in 2025Capitalize on high-growth stocks early - Jammu Links News
Is it the right time to buy Precision BioSciences Inc. stockUnprecedented market success - Jammu Links News
Published on: 2025-08-03 13:05:53 - Jammu Links News
What are analysts’ price targets for Precision BioSciences Inc. in the next 12 monthsFind the best stocks for sustainable growth - Jammu Links News
Precision Biosciences Inc (DTIL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.94%
1.72%
자본화:
|
볼륨(24시간):